CS172957B2 - - Google Patents

Info

Publication number
CS172957B2
CS172957B2 CS7906A CS591872A CS172957B2 CS 172957 B2 CS172957 B2 CS 172957B2 CS 7906 A CS7906 A CS 7906A CS 591872 A CS591872 A CS 591872A CS 172957 B2 CS172957 B2 CS 172957B2
Authority
CS
Czechoslovakia
Application number
CS7906A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS172957B2 publication Critical patent/CS172957B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8128Antithrombin III
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • Y10S530/831Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS7906A 1971-09-08 1972-08-28 CS172957B2 (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7111350A SE392038B (sv) 1971-09-08 1971-09-08 Forfarande for isolering av antitrombin ur blod eller blodprodukter

Publications (1)

Publication Number Publication Date
CS172957B2 true CS172957B2 (https=) 1977-01-28

Family

ID=20293800

Family Applications (1)

Application Number Title Priority Date Filing Date
CS7906A CS172957B2 (https=) 1971-09-08 1972-08-28

Country Status (22)

Country Link
US (1) US3842061A (https=)
JP (1) JPS5545528B2 (https=)
AT (1) AT324549B (https=)
AU (1) AU461865B2 (https=)
BE (1) BE787284A (https=)
CA (1) CA979805A (https=)
CH (1) CH577829A5 (https=)
CS (1) CS172957B2 (https=)
DE (1) DE2243688C3 (https=)
DK (1) DK131128B (https=)
ES (1) ES406199A1 (https=)
FI (1) FI50583C (https=)
FR (1) FR2154483B1 (https=)
GB (1) GB1356229A (https=)
HU (1) HU165070B (https=)
IE (1) IE36670B1 (https=)
IL (1) IL39982A (https=)
NL (1) NL154118B (https=)
NO (1) NO135302C (https=)
PL (1) PL83490B1 (https=)
SE (1) SE392038B (https=)
ZA (1) ZA726024B (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US4054557A (en) * 1974-05-15 1977-10-18 Ab Kabi Growth promoting polypeptides and preparation method
US4103685A (en) * 1976-01-05 1978-08-01 Lupien Paul J Method and apparatus for extravascular treatment of blood
NZ180198A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Cationic ion exchanger with a cross-linked carbohydrate marix
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
DE2916711A1 (de) 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
US4446314A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Fractionation of heparin
US4386025A (en) * 1980-09-30 1983-05-31 Cutter Laboratories, Inc. Method of preparing antithrombin
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung
FR2527222A1 (fr) * 1982-05-19 1983-11-25 Christine Fougnot Procede de separation et de purification des proteases et des antiproteases de la coagulation sanguine, ainsi que du complexe protease/antiprotease
US4632981A (en) * 1982-07-30 1986-12-30 Genentech, Inc. Human antithrombin III
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
AT379510B (de) * 1983-05-20 1986-01-27 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf) -haeltigen praeparation
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
CA1237998A (en) * 1984-04-14 1988-06-14 Akihiro Ginnaga Method for purification of filamentous hemagglutinin
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
CA1341379C (en) 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US5989593A (en) * 1996-11-20 1999-11-23 Yoshitomi Pharmaceutical Industries, Ltd. Method for producing antithrombin-III, method for purifying it, and preparation containing it
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
US8563693B2 (en) * 2001-01-26 2013-10-22 Acceleration Biopharmaceuticals, Inc. Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
EP1362127B1 (en) * 2001-01-26 2007-11-07 The General Hospital Corporation Serpin drugs for treatment of hiv infection and method of use thereof
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
MX2007002085A (es) 2004-08-20 2007-07-19 Prometic Biosciences Ltd Esquemas de aislamiento y purificacion consecutivos de proteinas mediante cromatografia de afinidad.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE366760B (https=) * 1967-12-18 1974-05-06 J Sjoevall
DE1907738A1 (de) * 1969-02-15 1970-08-13 Bayer Ag Verfahren zur Abtrennung des Trypsin-Plasmin-Inhibitors vom Thrombin-Inhibitor in handelsueblichen Hirudinpraeparaten und in Hirudinrohpraeparaten

Also Published As

Publication number Publication date
FI50583B (https=) 1976-02-02
NO135302B (https=) 1976-12-13
FI50583C (fi) 1976-05-10
DE2243688C3 (de) 1984-05-10
SU447876A3 (ru) 1974-10-25
GB1356229A (en) 1974-06-12
AU4637372A (en) 1974-03-14
FR2154483A1 (https=) 1973-05-11
DE2243688B2 (de) 1978-06-15
CH577829A5 (https=) 1976-07-30
IE36670L (en) 1973-03-08
JPS4835017A (https=) 1973-05-23
HU165070B (https=) 1974-06-28
NL7211953A (https=) 1973-03-12
IL39982A (en) 1974-11-29
AT324549B (de) 1975-09-10
CA979805A (en) 1975-12-16
IL39982A0 (en) 1972-09-28
DK131128B (da) 1975-06-02
ES406199A1 (es) 1975-07-01
ZA726024B (en) 1973-05-30
PL83490B1 (https=) 1975-12-31
NL154118B (nl) 1977-08-15
AU461865B2 (en) 1975-06-05
US3842061A (en) 1974-10-15
DK131128C (https=) 1975-11-03
JPS5545528B2 (https=) 1980-11-18
NO135302C (https=) 1977-03-23
DE2243688A1 (de) 1973-03-22
FR2154483B1 (https=) 1977-01-14
SE392038B (sv) 1977-03-14
BE787284A (fr) 1972-12-01
IE36670B1 (en) 1977-01-19

Similar Documents

Publication Publication Date Title
DK131128C (https=)
AU2952271A (https=)
AU2941471A (https=)
AU3005371A (https=)
AU2894671A (https=)
AU428077B2 (https=)
AU2940971A (https=)
AU2963771A (https=)
AU2880771A (https=)
AU2885171A (https=)
AU2415871A (https=)
AU2927871A (https=)
AU2875571A (https=)
AU2907471A (https=)
AU2938071A (https=)
AU2930871A (https=)
AU2837671A (https=)
AU2836771A (https=)
AU3025871A (https=)
AU3038671A (https=)
AU2854371A (https=)
CH561718A5 (https=)
CH560167A5 (https=)
BG16877A1 (https=)
BG16970A1 (https=)